C M Vollmer
Overview
Explore the profile of C M Vollmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balduzzi A, van der Heijde N, Alseidi A, Dokmak S, Kendrick M, Polanco P, et al.
Langenbecks Arch Surg
. 2020 Dec;
406(3):597-605.
PMID: 33301071
Purpose: The reported conversion rates for minimally invasive distal pancreatectomy (MIDP) range widely from 2 to 38%. The identification of risk factors for conversion may help surgeons during preoperative planning...
2.
Trudeau M, Maggino L, Ecker B, Vollmer C
J Gastrointest Surg
. 2019 Sep;
24(1):76-87.
PMID: 31485901
Purpose: This study aimed to identify optimal management decisions for surgeons preforming pancreatic head resection on patients with altered anatomy due to a previous Roux-en-Y gastric bypass (RYGB). Methods: A...
3.
Erdmann J, Eskens F, Vollmer C, Kok N, Koerkamp B, Biermann K, et al.
Ann Surg Oncol
. 2014 Dec;
22(7):2401-7.
PMID: 25503345
The benefit of adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma (PDAC) has been confirmed in randomized controlled trials. For nonpancreatic periampullary cancers (NPPC) originating from the distal bile duct, duodenum,...
4.
Sahajpal A, Vollmer C, Pollett A, Gallinger S
HPB (Oxford)
. 2008 Mar;
5(4):268-72.
PMID: 18333001
Background: Sclerosing lesions of the pancreatic duct are rare and may be secondary to primary sclerosing cholangitis (PSC) or the result of a primary sclerosing process (the recently described lymphoplasmacystic...
5.
Butterfield L, Meng W, Koh A, Vollmer C, Ribas A, Dissette V, et al.
J Immunol
. 2001 Apr;
166(8):5300-8.
PMID: 11290817
alpha fetoprotein (AFP)-derived peptide epitopes can be recognized by human T cells in the context of MHC class I. We determined the identity of AFP-derived peptides, presented in the context...
6.
Andrews K, Ribas A, Butterfield L, Vollmer C, Eilber F, Dissette V, et al.
Cancer Res
. 2000 Dec;
60(22):6457-64.
PMID: 11103813
The cytokine interleukin-12 (IL-12) has shown potent antitumor activity in several tumor models. Recently, natural killer (NK) T cells have been proposed to mediate the antitumor effects of IL-12. In...
7.
Ribas A, Butterfield L, McBride W, Dissette V, Koh A, Vollmer C, et al.
Cancer Gene Ther
. 1999 Dec;
6(6):523-36.
PMID: 10608349
A murine model of dendritic cell (DC)-based genetic immunization to a defined human melanoma antigen (Ag), MART-1/Melan-A (MART-1), was developed. The MART-1 gene was stably transfected into the nonimmunogenic mouse...
8.
Vollmer C, Ribas A, Butterfield L, Dissette V, Andrews K, Eilber F, et al.
Cancer Res
. 1999 Sep;
59(17):4369-74.
PMID: 10485485
An E1B gene-attenuated adenovirus (dl1520) has been proposed to have a selective cytolytic activity in cancer cells with a mutation or deletion in the p53 tumor suppressor gene (p53-null), a...
9.
Butterfield L, Koh A, Meng W, Vollmer C, Ribas A, Dissette V, et al.
Cancer Res
. 1999 Jul;
59(13):3134-42.
PMID: 10397256
Alpha-fetoprotein (AFP) is often derepressed in human hepatocellular carcinoma. Peptide fragments of AFP presented in the context of major histocompatibility molecules could serve as potential recognition targets by CD8 T...
10.
Ribas A, Bui L, Butterfield L, Vollmer C, Jilani S, Dissette V, et al.
Anticancer Res
. 1999 Jun;
19(2A):1165-70.
PMID: 10368670
Peptides extracted from tumor cells after mild acid treatment can function as antigenic epitopes when presented by cultured dendritic cells. Peptides were extracted from four tumors syngeneic to C3H mice,...